Characterization of a robust anti-Prelog short-chain dehydrogenase/reductase ChKRED20 from Chryseobacterium sp. CA49TANG, Tuo-Xian; YAN LIU; WU, Zhong-Liu et al.Journal of molecular catalysis. B, Enzymatic. 2014, Vol 105, pp 82-88, issn 1381-1177, 7 p.Article

Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomitingOLVER, I. N.International journal of clinical practice (Esher). 2004, Vol 58, Num 2, pp 201-206, issn 1368-5031, 6 p.Article

Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomitingNAKADE, Susumu; OHNO, Tomoya; KITAGAWA, Junsaku et al.Cancer chemotherapy and pharmacology. 2008, Vol 63, Num 1, pp 75-83, issn 0344-5704, 9 p.Article

Neurokinin-1 receptor antagonists in the prevention of postoperative nausea and vomitingDIEMUNSCH, P; JOSHI, G. P; BRICHANT, J.-F et al.British journal of anaesthesia. 2009, Vol 103, Num 1, pp 7-13, issn 0007-0912, 7 p.Article

An HPLC chromatographic reactor approach for investigating the hydrolytic stability of a pharmaceutical compoundSKRDLA, Peter J; ABRAHIM, Ahmed; YAN WU et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 41, Num 3, pp 883-890, issn 0731-7085, 8 p.Article

Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patientsNYGREN, Peter; HANDE, Kenneth; GOTTESDIENER, Keith M et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 6, pp 609-616, issn 0344-5704, 8 p.Article

Effect of aprepitant on the pharmacokinetics and pharmacodynamics of warfarinDEPRE, M; VAN HECKEN, A; BERGMAN, A et al.European journal of clinical pharmacology. 2005, Vol 61, Num 5-6, pp 341-346, issn 0031-6970, 6 p.Article

A sensitive and rapid liquid chromatography-tandem mass spectrometry method for the quantification of the novel neurokinin-1 receptor antagonist aprepitant in rhesus macaque plasma, and cerebral spinal fluid, and human plasma with application in translational NeuroAIDs researchDI WU; PAUL, Dustin J; XIANGUO ZHAO et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 49, Num 3, pp 739-745, issn 0731-7085, 7 p.Article

Safety and efficacy of a triple antiemetic combination with the NK-1 antagonist aprepitant in highly and moderately emetogenic multiple-day chemotherapyJORDAN, Karin; KINITZ, Iris; VOIGT, Wieland et al.European journal of cancer (1990). 2009, Vol 45, Num 7, pp 1184-1187, issn 0959-8049, 4 p.Article

Aprepitant : A novel antiemetic for chemotherapy-induced nausea and vomitingMASSARO, Alison M; LENZ, Kristi L.The Annals of pharmacotherapy. 2005, Vol 39, Num 1, pp 77-85, issn 1060-0280, 9 p.Article

Aprepitant for the control of chemotherapy induced nausea and vomiting in adolescentsSMITH, Angela R; REPKA, Tanya L; WEIGEL, Brenda J et al.Pediatric blood & cancer. 2005, Vol 45, Num 6, pp 857-860, issn 1545-5009, 4 p.Article

Antiemesis After Total Joint Arthroplasty: Does a Single Preoperative Dose of Aprepitant Reduce Nausea and Vomiting? : Complications of hip arthroplastyDILORIO, Timothy M; SHARKEY, Peter F; HEWITT, Agnes M et al.Clinical orthopaedics and related research. 2010, Vol 468, Num 9, pp 2405-2409, issn 0009-921X, 5 p.Article

Human Positron emission tomography studies of Brain neurokinin 1 receptor occupancy by AprepitantBERGSTROM, Mats; HARGREAVES, Richard J; ESKOLA, Olli et al.Biological psychiatry (1969). 2004, Vol 55, Num 10, pp 1007-1012, issn 0006-3223, 6 p.Article

Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapyUCHIDA, Mayako; IKESUE, Hiroaki; EGASHIRA, Nobuaki et al.American journal of health-system pharmacy. 2013, Vol 70, Num 4, pp 343-349, issn 1079-2082, 7 p.Article

Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteersCHIZH, B. A; GOHRING, M; TRÖSTER, A et al.British Journal of Anaesthesia. 2007, Vol 98, Num 2, pp 246-254, issn 0007-0912, 9 p.Article

Cytochrome P450 3A4 is the major enzyme involved in the metabolism of the substance P receptor antagonist aprepitantSANCHEZ, Rosa I; WANG, Regina W; NEWTON, Deborah J et al.Drug metabolism and disposition. 2004, Vol 32, Num 11, pp 1287-1292, issn 0090-9556, 6 p.Article

Aprepitant plus Ondansetron Compared with Ondansetron Alone in Reducing Postoperative Nausea and Vomiting in Ambulatory Patients Undergoing Plastic SurgeryVALLEJO, Manuel C; PHELPS, Amy L; IBINSON, James W et al.Plastic and reconstructive surgery (1963). 2012, Vol 129, Num 2, pp 519-526, issn 0032-1052, 8 p.Article

Actualités sur les nausées et les vomissements en 2010 : Mises au point du 46^e congrès de Chicago en oncologie clinique (4-8 juin) et de la MASCC Multinational Assciation of Supportive Care in Cancer (Vancouver, 24-26 juin)SCOTTE, Florian.La Lettre du cancérologue (Boulogne). 2010, Vol 19, issn 1165-113X, 7 p., SUP2Serial Issue

Addition of aprepitant improves protection against cisplatin-induced emesis when a conventional anti-emetic regimen failsWEIHENG HU; JIAN FANG; JUN NIE et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1129-1136, issn 0344-5704, 8 p.Article

Korean red ginseng extract ameliorates skin lesions in NC/Nga mice: An atopic dermatitis modelJI HYUN LEE; SANG HYUN CHO.Journal of ethnopharmacology. 2011, Vol 133, Num 2, pp 810-817, issn 0378-8741, 8 p.Article

Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in GermanyLORDICK, Florian; EHLKEN, Birgit; IHBE-HEFFINGER, Angela et al.European journal of cancer (1990). 2007, Vol 43, Num 2, pp 299-307, issn 0959-8049, 9 p.Article

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatmentSCHMOLL, H. J; AAPRO, M. S; POLI-BIGELLI, S et al.Annals of oncology. 2006, Vol 17, Num 6, pp 1000-1006, issn 0923-7534, 7 p.Article

Efficacy of aprepitant in preventing nausea and vomiting due to high-dose melphalan-based conditioning for allogeneic hematopoietic stem cell transplantationSAKURAI, Masatoshi; MORI, Takehiko; BEPPU, Noriko et al.International journal of hematology. 2014, Vol 99, Num 4, pp 457-462, issn 0925-5710, 6 p.Article

Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell TransplantationUCHIDA, Mayako; KATO, Koji; TESHIMA, Takanori et al.Pharmacotherapy. 2013, Vol 33, Num 9, pp 893-901, issn 0277-0008, 9 p.Article

Safety of neurokinin-1 receptor antagonistsMUNOZ, Miguel; COVENAS, Rafael.Expert opinion on drug safety. 2013, Vol 12, Num 5, pp 673-685, issn 1474-0338, 13 p.Article